Advanced Diagnostic Screening

Whole-body MRI, coronary calcium scoring, whole-genome sequencing, and multi-cancer blood tests sold to people without symptoms. The most expensive layer of most advanced longevity programs, and the one with the widest evidence spread.

Imaging and genomic screening Mixed, depends on components $650 to $2,500 per scan; $300 to $1,500 per genomic panel (varies) Regulated imaging and lab tests; screening use in people without symptoms falls outside most guidelines

Advanced diagnostic screening is the layer that separates a longevity membership from a good annual physical, and it is priced accordingly. The components sit on very different rungs of the evidence ladder, which is why they need to be evaluated one at a time rather than as a package.

Coronary artery calcium scoring is the best-supported item. Cardiology guidelines allow it to refine treatment decisions for adults at intermediate cardiovascular risk, and a score of zero can reasonably delay statin therapy in some people. Whole-body MRI is the opposite case. The American College of Radiology stated in 2023 that there is not sufficient evidence to recommend total body screening for people without symptoms, risk factors, or a suggestive family history, and the known downside is a high rate of incidental findings that lead to more imaging, biopsies, and anxiety without a demonstrated survival benefit. Multi-cancer early detection blood tests are promising research tools with large prospective trials still underway; none has yet shown that it reduces cancer deaths.

Genomic testing splits the same way. Sequencing can identify inherited conditions such as familial hypercholesterolemia or BRCA variants, where the result changes management. Polygenic risk scores for common diseases add modest information on top of standard risk tools for most people. A program that sells the whole menu to every member is selling the scan, not the decision it is supposed to inform.

What It Usually Includes

  • Whole-body MRI marketed as early cancer detection
  • Coronary artery calcium CT scan
  • Whole-genome sequencing or polygenic risk scores
  • Multi-cancer early detection blood tests
  • DEXA body composition and bone density
  • Carotid ultrasound and other vascular imaging

Red Flags

  • Every member gets the same scans regardless of age, symptoms, or family history
  • Incidental findings are described as lives saved without follow-up data
  • AI-enhanced reading is advertised with no published validation
  • A multi-cancer blood test is presented as proven to reduce cancer deaths
  • There is no radiologist-led plan for indeterminate findings

Questions to Ask Before Paying

  • What is the false positive rate of this scan in people like me?
  • Who reads the images, and what happens when a finding is indeterminate?
  • Is coronary calcium scoring indicated for my cardiovascular risk level?
  • Has this multi-cancer test shown a mortality benefit in a completed trial?
  • Which of these results would change what my physician recommends?
Educational content: This page covers ongoing scientific research. Evidence levels vary. Nothing here is medical advice. Consult qualified medical professionals before making health decisions.